These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24385731)

  • 1. Intramesenteric steroid treatment for steroid- refractory gastrointestinal graft versus host disease.
    Bilgin AU; Topcuoğlu P; Sancak T; Konuk N; Arat M
    Turk J Haematol; 2012 Dec; 29(4):409-12. PubMed ID: 24385731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of gastrointestinal graft-versus-host disease according to the treatment response.
    Tamaki M; Nakasone H; Misaki Y; Yoshimura K; Gomyo A; Hayakawa J; Kusuda M; Akahoshi Y; Ishihara Y; Kawamura K; Tanihara A; Sato M; Terasako-Saito K; Kameda K; Wada H; Kikuchi M; Kimura SI; Kako S; Kanda Y
    Ann Hematol; 2018 Oct; 97(10):1951-1960. PubMed ID: 29860563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial catheter directed therapy for severe graft-versus-host disease.
    Shapira MY; Bloom AI; Or R; Sasson T; Nagler A; Resnick IB; Aker M; Zilberman I; Slavin S; Verstanding A
    Br J Haematol; 2002 Dec; 119(3):760-4. PubMed ID: 12437655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial catheter guided steroid administration for the treatment of steroid-refractory intestinal GvHD.
    Bürgler D; Medinger M; Passweg J; Fischmann A; Bucher C
    Leuk Res; 2014 Feb; 38(2):184-7. PubMed ID: 24268317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial methylprednisolone for severe steroid refractory gastrointestinal graft-versus-host disease.
    Bhuller KS; Heran MK; Wu JK; Rassekh SR
    Pediatr Blood Cancer; 2014 Dec; 61(12):2321-3. PubMed ID: 25053422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intra-arterial steroid infusions in patients with steroid-resistant gastrointestinal acute graft-versus-host disease.
    Nishimoto M; Koh H; Hirose A; Nakamae M; Nakane T; Hayashi Y; Okamura H; Yoshimura T; Koh S; Nanno S; Nakashima Y; Takeshita T; Yamamoto A; Sakai Y; Nishida N; Matsuoka T; Miki Y; Hino M; Nakamae H
    Exp Hematol; 2015 Dec; 43(12):995-1000. PubMed ID: 26303639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
    Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
    Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease.
    Adam B; Koldehoff M; Ditschkowski M; Gromke T; Hlinka M; Trenschel R; Kordeals L; Steckel NK; Beelen DW; Liebregts T
    Dig Dis Sci; 2016 Jul; 61(7):2019-26. PubMed ID: 26995779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of intra-arterial steroid administration for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease.
    Bérczi V; Tóth A; Tatai G; Fábián J; Reményi P; Masszi T
    Clin Radiol; 2019 Apr; 74(4):301-305. PubMed ID: 30691732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.
    Sung AD; Hassan S; Cardona DM; Wild D; Nichols KR; Mehdikhani H; Balmadrid B; Detweiler CJ; Shealy M; Cirrincione C; Li Z; Poleski M; Dalton TE; Siamakpour-Reihani S; Chao NJ; Sullivan KM
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):734-740. PubMed ID: 29246821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive Dietary Therapy Is Associated With Improved Gastrointestinal Symptoms in Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease: A Case Series.
    Kaenkumchorn T; Suskind DL; Lee D; Singh N; Ford M; Skeen K; Macris PC; Yeung C; Summers C; Carpenter PA; Zheng HB
    JPGN Rep; 2022 May; 3(2):e203. PubMed ID: 37168898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cell Therapy Overcomes Steroid Resistance in Severe Gastrointestinal Acute Graft-Versus-Host Disease.
    Moritani K; Miyawaki R; Tokuda K; Ochi F; Eguchi-Ishimae M; Tauchi H; Eguchi M; Ishii E; Nagai K
    Case Rep Transplant; 2019; 2019():7890673. PubMed ID: 31263624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Potential of Mesenchymal Stromal Cells as Treatment for Severe Steroid-Refractory Acute Graft-Versus-Host Disease: A Critical Review of the Literature.
    Munneke JM; Spruit MJ; Cornelissen AS; van Hoeven V; Voermans C; Hazenberg MD
    Transplantation; 2016 Nov; 100(11):2309-2314. PubMed ID: 26714122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inpatient Healthcare Resource Utilization, Costs, and Mortality in Adult Patients with Acute Graft-versus-Host Disease, Including Steroid-Refractory or High-Risk Disease, following Allogeneic Hematopoietic Cell Transplantation.
    Yu J; Judy JT; Parasuraman S; Sinha M; Weisdorf D
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):600-605. PubMed ID: 31678539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease.
    Broglie L; Rademaker A; Galvin J; Ray A; Tse WT; Duerst R; Schneiderman J; Kletzel M; Chaudhury S
    Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):169-174. PubMed ID: 29397331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial methylprednisolone infusion in treatment-resistant graft-versus-host disease.
    Weintraub JL; Belanger AR; Sung CC; Stangl PA; Nowakowski FS; Lookstein RL
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):509-12. PubMed ID: 20063098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantation.
    Pagliuca S; Prata PH; Xhaard A; Frieri C; Giannoni L; Sutra Del Galy A; Brignier A; Sicre de Fontbrune F; Michonneau D; Dhedin N; Peffault de Latour R; Socié G; Robin M
    Bone Marrow Transplant; 2021 Jan; 56(1):38-49. PubMed ID: 32587336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
    Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
    Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of intra-arterial steroid administration in the management of steroid-refractory acute gastrointestinal graft-versus-host disease.
    Tfayli A; Selby G; Maqbool F; Bierbaum W; Hamadani M
    Am J Hematol; 2006 Dec; 81(12):959-62. PubMed ID: 16924649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor necrosis factor-a for the treatment of steroid-refractory acute graft-versus-host disease.
    Nogueira MC; Azevedo AM; Pereira SC; Ferreira JL; Lerner D; Lobo AM; Tavares RC; Tabak DG; Lorenzi N; Renault IZ; Bouzas LF
    Braz J Med Biol Res; 2007 Dec; 40(12):1623-9. PubMed ID: 17713663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.